[METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN HEALTHY PERSONS AND IN PATIENTS WITH ISCHEMIC HEART DISEASES. 3. CRITICAL EXAMINATION OF THE RESULTS AND CONCLUSIVE CONSIDERATIONS].
D001713:Biphenyl Compounds; D001794:Blood Pressure; D002395:Catecholamines; D002784:Cholesterol / Q000097:blood*; D006333:Heart Failure; D008660:Metabolism; D009203:Myocardial Infarction; D010600:Pharmacology; D011299:Prenylamine; D012701:Serotonin; D014508:Urea; D014882:Water-Electrolyte Balance
D001713:Biphenyl Compounds; D002395:Catecholamines; D002784:Cholesterol; D011299:Prenylamine; D012701:Serotonin; D014508:Urea; C010574:biphenyl
BLOOD CHOLESTEROL; BLOOD PRESSURE; CATECHOLAMINES; HEART FAILURE, CONGESTIVE; METABOLISM; MYOCARDIAL INFARCT; PHARMACOLOGY; PRENYLAMINE; SEROTONIN; UREA; WATER-ELECTROLYTE BALANCE
EFFETTI METABOLICI DELLA FENIL-PROPIL-DIFENIL-PROPIL-AMINA NELL'UOMO SANO E NEL MALATO DI CARDIOPATIA ISCHEMICA. 3. ESAME CRITICO DEI RISULTATI E CONSIDERAZIONI CONCLUSIVE.